Anil K. Rustgi shares his thoughts on how COVID-19 has shown that coordinating efforts across all aspects of science are vital to the success of our fight against this infectious disease.
Welcome to Apar Gupta, MD, MBA, and Catherine (Katie) Spina, MD, PhD, joining the Department of Radiation Oncology at Columbia University Irving Medical Center (CUIMC) effective September 1.
The Herbert Irving Comprehensive Cancer Center (HICCC) has been competitively renewed as a designated Comprehensive Cancer Center by the federal government’s National Cancer Institute (NCI).
Congratulations to 14 teams of Columbia faculty that have been awarded a Columbia Life Science Accelerator grant to support cutting-edge translational research.
A large observational study in Cancer Discovery examined the association of COVID-19 treatments with 30-day all-cause mortality, as well as sociodemographic factors associated with treatment.
Columbia University’s Division of Hematology and Oncology welcomes new members, Andrew Lipsky, MD, and Aaron Viny, MD, MS, both assistant professors of medicine, to the leukemia group.
Congratulations to HICCC clinicians and scientists at Columbia’s Department of Radiation Oncology for their latest achievements, awards, and milestones - August 2020
Beatriz Duran-Becerra arrived at Columbia University in 2014 and found support and guidance from the Continuing Umbrella of Research Experiences (CURE) program.
